Marker Therapeutics Employee Stock Option Plan Debt Guarantee (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.57 +0.02 (+1.29%) USD | NASDAQ | Feb 26, 15:54

View Employee Stock Option Plan Debt Guarantee (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Employee Stock Option Plan Debt Guarantee (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Employee Stock Option Plan Debt Guarantee (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Employee Stock Option Plan Debt Guarantee (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--